FR2823221B1 - Sequences associees a la degenerescence retinienne et applications - Google Patents
Sequences associees a la degenerescence retinienne et applicationsInfo
- Publication number
- FR2823221B1 FR2823221B1 FR0104712A FR0104712A FR2823221B1 FR 2823221 B1 FR2823221 B1 FR 2823221B1 FR 0104712 A FR0104712 A FR 0104712A FR 0104712 A FR0104712 A FR 0104712A FR 2823221 B1 FR2823221 B1 FR 2823221B1
- Authority
- FR
- France
- Prior art keywords
- syndrome
- age
- protein
- applications
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Priority Applications (30)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0104712A FR2823221B1 (fr) | 2001-04-06 | 2001-04-06 | Sequences associees a la degenerescence retinienne et applications |
HU0303730A HU226307B1 (en) | 2001-04-06 | 2002-04-05 | Disease-associated protein |
SK1223-2003A SK288465B6 (sk) | 2001-04-06 | 2002-04-05 | Izolovaný polypeptid a nukleová kyselina a farmaceutická kompozícia, ktorá ich obsahuje, na diagnostiku, prevenciu a liečenie degeneratívnych ochorení sietnice |
PL364681A PL213658B1 (pl) | 2001-04-06 | 2002-04-05 | Kompozycje farmaceutyczne zawierajace terapeutycznie skuteczna ilosc polipeptydu; kompozycje farmaceutyczne zawierajace terapeutycznie skuteczna ilosc kwasu nukleinowego; zastosowanie wspomnianych polipeptydów, czasteczek kwasu nukleinowego, kwasu nukleinowego i wektora zawierajacego kwas nukleinowy; sposoby diagnozowania dystrofii siatkówki; izolowany polipeptyd; sposób jego wytwarzania; oczyszczone przeciwcialo lub jego fragment oraz zestaw do diagnozowania dystrofii siatkówki |
MXPA03009114A MXPA03009114A (es) | 2001-04-06 | 2002-04-05 | Proteina asociada con enfermedad. |
CN028094700A CN1529753B (zh) | 2001-04-06 | 2002-04-05 | 疾病相关蛋白质 |
ES02737923.9T ES2597835T3 (es) | 2001-04-06 | 2002-04-05 | Proteína asociada a enfermedad |
RU2003130638/13A RU2384586C2 (ru) | 2001-04-06 | 2002-04-05 | Протеин, связанный с заболеванием |
US10/473,008 US7795387B2 (en) | 2001-04-06 | 2002-04-05 | Rod-derived cone viability factor (RDCVF) and a method of enhancing cone cell survival by RDCVF |
EP02737923.9A EP1379657B1 (fr) | 2001-04-06 | 2002-04-05 | Proteine associee a une maladie |
CA2443345A CA2443345C (fr) | 2001-04-06 | 2002-04-05 | Proteine associee a une maladie |
IL15801302A IL158013A0 (en) | 2001-04-06 | 2002-04-05 | Disease-associated protein |
KR1020037012934A KR100913258B1 (ko) | 2001-04-06 | 2002-04-05 | 질환-관련 단백질 |
CZ2003-2706A CZ305800B6 (cs) | 2001-04-06 | 2002-04-05 | Farmaceutická kompozice, způsob diagnostiky retinální dystrofie, rekombinantní polypeptid, způsob produkce tohoto polypeptidu, rekombinantní protilátka a její fragment |
AU2002312794A AU2002312794B8 (en) | 2001-04-06 | 2002-04-05 | Disease-associated protein |
BRPI0208870A BRPI0208870B8 (pt) | 2001-04-06 | 2002-04-05 | método de produção de polipeptídeos, vetor, composição farmacêutica, bem como método para diagnóstico de distrofia retinal |
PCT/EP2002/003810 WO2002081513A2 (fr) | 2001-04-06 | 2002-04-05 | Proteine associee a une maladie |
JP2002579898A JP4370428B2 (ja) | 2001-04-06 | 2002-04-05 | 疾患関連タンパク質 |
NZ528376A NZ528376A (en) | 2001-04-06 | 2002-04-05 | Rod derived cone viability factor (RdcvF) and its use in the treatment of retinal dystrophy |
EC2002004345A ECSP024345A (es) | 2001-04-06 | 2002-11-19 | Proteina asociada con enfermedad |
IL158013A IL158013A (en) | 2001-04-06 | 2003-09-18 | Isolated polypeptide and pharmaceutical composition comprising it for the diagnosis of retinal dystrophy and use thereof in the preparation of a medicament for the treatment of retinal dystrophy |
ZA200307403A ZA200307403B (en) | 2001-04-06 | 2003-09-23 | Disease-associasted protein. |
NO20034452A NO331277B1 (no) | 2001-04-06 | 2003-10-03 | Farmasoytisk sammensetning omfattende polypetid/nukleinsyre for behandling av retinale degenererende sykdommer, vektor, isolert polypeptid, renset antistoff og anvendelse av polypeptid, nukleinsyre og antistoff, samt fremgangsmater og kit |
US11/739,739 US8114849B2 (en) | 2001-04-06 | 2007-04-25 | Retinal dystrophy-associated protein and uses thereof |
US11/739,734 US8071745B2 (en) | 2001-04-06 | 2007-04-25 | Polynucleotides encoding rod-derived cone viability factor (rdcvf) and methods of using the same |
JP2009050689A JP4571695B2 (ja) | 2001-04-06 | 2009-03-04 | 疾患関連タンパク質 |
IL199316A IL199316A (en) | 2001-04-06 | 2009-06-11 | An antibody is cleared and a kit that includes it for diagnosing retinal dystrophy |
US13/348,383 US8394756B2 (en) | 2001-04-06 | 2012-01-11 | Methods of increasing RDCVF 1 or RDCVF 2 polypeptides in retinal cells |
US13/348,435 US8518695B2 (en) | 2001-04-06 | 2012-01-11 | Compositions comprising polynucleotides encoding RDCVF1 or RDCVF2 |
US13/909,764 US8957043B2 (en) | 2001-04-06 | 2013-06-04 | Methods of treating retinitis pigmentosa using nucleic acids encoding RDCVF1 or RDCVF2 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0104712A FR2823221B1 (fr) | 2001-04-06 | 2001-04-06 | Sequences associees a la degenerescence retinienne et applications |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2823221A1 FR2823221A1 (fr) | 2002-10-11 |
FR2823221B1 true FR2823221B1 (fr) | 2004-04-02 |
Family
ID=8862037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0104712A Expired - Lifetime FR2823221B1 (fr) | 2001-04-06 | 2001-04-06 | Sequences associees a la degenerescence retinienne et applications |
Country Status (22)
Country | Link |
---|---|
US (6) | US7795387B2 (fr) |
EP (1) | EP1379657B1 (fr) |
JP (2) | JP4370428B2 (fr) |
KR (1) | KR100913258B1 (fr) |
CN (1) | CN1529753B (fr) |
AU (1) | AU2002312794B8 (fr) |
BR (1) | BRPI0208870B8 (fr) |
CA (1) | CA2443345C (fr) |
CZ (1) | CZ305800B6 (fr) |
EC (1) | ECSP024345A (fr) |
ES (1) | ES2597835T3 (fr) |
FR (1) | FR2823221B1 (fr) |
HU (1) | HU226307B1 (fr) |
IL (3) | IL158013A0 (fr) |
MX (1) | MXPA03009114A (fr) |
NO (1) | NO331277B1 (fr) |
NZ (1) | NZ528376A (fr) |
PL (1) | PL213658B1 (fr) |
RU (1) | RU2384586C2 (fr) |
SK (1) | SK288465B6 (fr) |
WO (1) | WO2002081513A2 (fr) |
ZA (1) | ZA200307403B (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2823221B1 (fr) | 2001-04-06 | 2004-04-02 | Univ Pasteur | Sequences associees a la degenerescence retinienne et applications |
DE602004030327D1 (de) | 2003-05-21 | 2011-01-13 | Genzyme Corp | Verfahren zur herstellung von präparationen rekombinanter aav-virionen, die weitgehend frei von leeren capsiden sind |
FR2870241B1 (fr) * | 2004-05-13 | 2015-02-27 | Novartis Ag | Facteur de viabilite des cones derive des batonnets ou rdcvf et applications |
EP2027889A1 (fr) * | 2007-06-05 | 2009-02-25 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Nouveau facteur de viabilité neuronale et son utilisation |
US9567382B2 (en) * | 2008-04-15 | 2017-02-14 | Genzyme Corporation | Methods to produce rod-derived cone viability factor (RdCVF) |
US8779093B2 (en) | 2008-09-10 | 2014-07-15 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Neuronal viability factor and use thereof |
EP2383286A1 (fr) | 2010-04-30 | 2011-11-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Procédés et compositions pour le traitement des maladies rétiniennes dégénératives |
WO2013063383A2 (fr) | 2011-10-27 | 2013-05-02 | Wellstat Ophthalmics Corporation | Vecteurs codant pour un facteur de viabilité des cônes dérivé des bâtonnets |
WO2013124477A1 (fr) | 2012-02-24 | 2013-08-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Procédés et compositions pour le traitement de maladies dégénératives de la rétine |
ES2796737T3 (es) | 2012-10-17 | 2020-11-30 | Inst Nat Sante Rech Med | Métodos y composiciones farmacéuticas para el tratamiento de la degeneración macular relacionada con la edad (AMD) |
CN105593239B (zh) | 2013-07-31 | 2020-10-16 | 诺华股份有限公司 | 选择真核宿主细胞的选择载体和方法 |
WO2016185242A1 (fr) * | 2015-05-21 | 2016-11-24 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Combinaison synergique de facteurs de viabilité neuronale et utilisations associées |
WO2017120294A1 (fr) | 2016-01-05 | 2017-07-13 | The Trustees Of The University Of Pennsylvania | Méthodes et compositions pour le traitement des troubles oculaires et des maladies susceptibles de provoquer une cécité |
MX2018015596A (es) * | 2016-10-11 | 2019-03-14 | Wellstat Ophthalmics Corp | Proteina de fusion entre el factor de viabilidad de los conos derivado de bastones de forma corta y un peptido hidrofilo. |
CN113260704B (zh) * | 2019-12-09 | 2022-06-28 | 北京中因科技有限公司 | CYP4V2和RdCVF在制备药物中的用途 |
CN111733174B (zh) * | 2020-08-07 | 2021-02-09 | 北京大学第三医院(北京大学第三临床医学院) | 一种分离的核酸分子及其用途 |
WO2023280926A1 (fr) * | 2021-07-07 | 2023-01-12 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Combinaison synergique de rdcfv2 et rdcvf2l destinée au traitement de tauopathies |
CN113774019B (zh) * | 2021-08-11 | 2024-02-13 | 东南大学 | 一种脐带血间充质干细胞无血清培养基、培养方法及其应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4771036A (en) * | 1986-02-10 | 1988-09-13 | Trustees Of Columbia University In The City Of New York | Method and ophthalmic composition for the prevention and reversal of cataracts |
GB9701710D0 (en) * | 1997-01-28 | 1997-03-19 | Karobio Ab | Mammalian protein |
US6106825A (en) * | 1997-05-07 | 2000-08-22 | University Of Florida | Entomopoxvirus-vertebrate gene delivery vector and method |
FR2784030B1 (fr) | 1998-10-02 | 2002-12-20 | Inst Nat Sante Rech Med | Utilisation de bloqueurs des canaux calciques et/ou cgmp-dependants pour le traitement de pathologies de la retine |
FR2784898A1 (fr) | 1998-10-26 | 2000-04-28 | Univ Pasteur | Utilisation du gdnf pour le traitement de la degenerescence retinienne |
EP1033405A3 (fr) * | 1999-02-25 | 2001-08-01 | Ceres Incorporated | Fragments d'ADN avec des séquences déterminées et polypeptides encodées par lesdits fragments |
CA2402563A1 (fr) * | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Nouveaux acides nucleiques et polypeptides |
FR2823221B1 (fr) | 2001-04-06 | 2004-04-02 | Univ Pasteur | Sequences associees a la degenerescence retinienne et applications |
US20060275794A1 (en) | 2005-03-07 | 2006-12-07 | Invitrogen Corporation | Collections of matched biological reagents and methods for identifying matched reagents |
US8779093B2 (en) | 2008-09-10 | 2014-07-15 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Neuronal viability factor and use thereof |
-
2001
- 2001-04-06 FR FR0104712A patent/FR2823221B1/fr not_active Expired - Lifetime
-
2002
- 2002-04-05 IL IL15801302A patent/IL158013A0/xx unknown
- 2002-04-05 HU HU0303730A patent/HU226307B1/hu unknown
- 2002-04-05 MX MXPA03009114A patent/MXPA03009114A/es active IP Right Grant
- 2002-04-05 CZ CZ2003-2706A patent/CZ305800B6/cs not_active IP Right Cessation
- 2002-04-05 KR KR1020037012934A patent/KR100913258B1/ko active IP Right Grant
- 2002-04-05 WO PCT/EP2002/003810 patent/WO2002081513A2/fr active IP Right Grant
- 2002-04-05 PL PL364681A patent/PL213658B1/pl unknown
- 2002-04-05 JP JP2002579898A patent/JP4370428B2/ja not_active Expired - Lifetime
- 2002-04-05 SK SK1223-2003A patent/SK288465B6/sk unknown
- 2002-04-05 ES ES02737923.9T patent/ES2597835T3/es not_active Expired - Lifetime
- 2002-04-05 EP EP02737923.9A patent/EP1379657B1/fr not_active Expired - Lifetime
- 2002-04-05 CA CA2443345A patent/CA2443345C/fr not_active Expired - Lifetime
- 2002-04-05 NZ NZ528376A patent/NZ528376A/en not_active IP Right Cessation
- 2002-04-05 CN CN028094700A patent/CN1529753B/zh not_active Expired - Lifetime
- 2002-04-05 AU AU2002312794A patent/AU2002312794B8/en not_active Expired
- 2002-04-05 RU RU2003130638/13A patent/RU2384586C2/ru active
- 2002-04-05 BR BRPI0208870A patent/BRPI0208870B8/pt not_active IP Right Cessation
- 2002-04-05 US US10/473,008 patent/US7795387B2/en active Active
- 2002-11-19 EC EC2002004345A patent/ECSP024345A/es unknown
-
2003
- 2003-09-18 IL IL158013A patent/IL158013A/en unknown
- 2003-09-23 ZA ZA200307403A patent/ZA200307403B/en unknown
- 2003-10-03 NO NO20034452A patent/NO331277B1/no not_active IP Right Cessation
-
2007
- 2007-04-25 US US11/739,734 patent/US8071745B2/en not_active Expired - Fee Related
- 2007-04-25 US US11/739,739 patent/US8114849B2/en not_active Expired - Fee Related
-
2009
- 2009-03-04 JP JP2009050689A patent/JP4571695B2/ja not_active Expired - Lifetime
- 2009-06-11 IL IL199316A patent/IL199316A/en active IP Right Grant
-
2012
- 2012-01-11 US US13/348,435 patent/US8518695B2/en not_active Expired - Lifetime
- 2012-01-11 US US13/348,383 patent/US8394756B2/en not_active Expired - Lifetime
-
2013
- 2013-06-04 US US13/909,764 patent/US8957043B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2823221B1 (fr) | Sequences associees a la degenerescence retinienne et applications | |
EP2182006A3 (fr) | Compositions et procédés pour le traitement de maladies liées au système immunitaire | |
WO2005011599A3 (fr) | Anticorps specifiques des oligomeres a proteines beta amyloides toxiques | |
EP2322200A3 (fr) | Les compositions et les methodes pour le traitement de maladies liées immunisées | |
EP2213684A3 (fr) | Anticorps nogo-a pour le traitement de la maladie d'Alzheimer | |
WO2002046222A3 (fr) | Compositions et procede de diagnostic de la maladie d'alzheimer | |
WO2008063369A3 (fr) | Biomarqueurs pour états neurologiques | |
CY1107146T1 (el) | Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad) | |
ES2170104T3 (es) | Inhibidores de la produccion de proteinas de beta-amiloide. | |
TR200100377T2 (tr) | Aß Protein üretimi inhibitörleri olarak sukinoilamino laktamlar. | |
EP2426143A3 (fr) | Procédé pour fournir des molécules de liaison et des cibles spécifiques à une maladie | |
WO2005018424A3 (fr) | Anticorps specifiques de la proteine amyloide fibrillaire et procedure permettant de detecter des depots de proteines amyloides fibrillaires | |
WO2007011834A3 (fr) | Composes et procede pour diagnostiquer et traiter les maladies associees aux amyloides | |
WO2006052821A3 (fr) | Compositions et procedes de traitement de pliage errone de proteines et maladies liees a l'aggregation de proteines | |
ATE506957T1 (de) | Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen | |
WO2005113586A3 (fr) | Proteines associees a des maladies | |
BRPI0414868A (pt) | composições e métodos compreendendo compostos relacionados com prostaglandina e peptìdios da famìlia do fator trifoliado para o tratamento de glaucoma com hiperemia reduzida | |
WO2004024072A3 (fr) | Nouvelles compositions et methodes pour le traitement de maladies associees au systeme immunitaire | |
DE60208180D1 (de) | Modifiziertes, als medikamentvorstufe anwendbares cyclosporin und dessen verwendung | |
WO2007030708A3 (fr) | Adzymes antimicrobiens et leurs utilisations | |
NO20054346L (no) | Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander | |
EP1891947A3 (fr) | Utilisation de (R)-vérapamil pour le traitement d'augmentations anormales de la motilité gastro-intestinale | |
WO2001007479A3 (fr) | Matieres vivantes et methodes utiles pour le diagnostic ou le traitement de maladies | |
ATE547431T1 (de) | Single-chain-antikörper gegen den 37 kda/67 kda lamininrezeptor als werkzeuge zur diagnose und therapie von prionerkrankungen und krebs, deren herstellung und verwendung | |
WO2001040465A3 (fr) | Compositions et procedes de traitement de maladies d'ordre immunologique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 16 |
|
PLFP | Fee payment |
Year of fee payment: 17 |
|
PLFP | Fee payment |
Year of fee payment: 18 |
|
PLFP | Fee payment |
Year of fee payment: 20 |